Evidence map›Paper›PMID 29970082›Full record

ArticleMicrobial cell factories2018

Engineering de novo anthocyanin production in Saccharomyces cerevisiae.

Mark Levisson, Constantinos Patinios, Sascha Hein, Philip A de Groot, Jean-Marc Daran, Robert D Hall, Stefan Martens, Jules Beekwilder

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Enzyme promiscuity-driven co-production of flavonoid 7-Synthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. A major facilitator superfamily transporter MdtH inApplied and environmental microbiology · 2024
    Article
  7. Identification ofFrontiers in microbiology · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Elimination of aromatic fusel alcohols as by-products ofMetabolic engineering communications · 2021
    Article
  17. Article
  18. Review
  19. Frontiers in bioengineering and biotechnology · 2021
    Article
  20. International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mark LevissonLaboratory of Plant Physiology, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Constantinos PatiniosLaboratory of Plant Physiology, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Sascha HeinDepartment of Food Quality and Nutrition, Fondazione Edmund Mach, Centro Ricerca e Innovazione, Via E. Mach, 1, 38010, San Michele all'Adige, TN, Italy.
Philip A de GrootDepartment of Biotechnology, Delft University of Technology, van der Maasweg 9, 2629 HZ, Delft, The Netherlands.
Jean-Marc DaranDepartment of Biotechnology, Delft University of Technology, van der Maasweg 9, 2629 HZ, Delft, The Netherlands.ORCID http://orcid.org/0000-0003-3136-8193
Robert D HallLaboratory of Plant Physiology, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands.
Stefan MartensDepartment of Food Quality and Nutrition, Fondazione Edmund Mach, Centro Ricerca e Innovazione, Via E. Mach, 1, 38010, San Michele all'Adige, TN, Italy.ORCID http://orcid.org/0000-0001-9913-4882
Jules BeekwilderWageningen Plant Research, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB, Wageningen, The Netherlands. Jules.Beekwilder@wur.nl.ORCID http://orcid.org/0000-0003-3238-4427
Wageningen University & Research · NLDelft University of Technology · NLFondazione Edmund Mach · IT

Funding

Autonomous Province of Trento ADP 2011-2018EU 7th framework FP7-KBBE-2009-3-245121-ATHENANederlandse Organisatie voor Wetenschappelijk Onderzoek ECHO grant 713.015.001
6 · The paper itself

Abstract

backgroundAnthocyanins are polyphenolic pigments which provide pink to blue colours in fruits and flowers. There is an increasing demand for anthocyanins, as food colorants and as health-promoting substances. Plant production of anthocyanins is often seasonal and cannot always meet demand due to low productivity and the complexity of the plant extracts. Therefore, a system of on-demand supply is useful. While a number of other (simpler) plant polyphenols have been successfully produced in the yeast Saccharomyces cerevisiae, production of anthocyanins has not yet been reported.

resultsSaccharomyces cerevisiae was engineered to produce pelargonidin 3-O-glucoside starting from glucose. Specific anthocyanin biosynthetic genes from Arabidopsis thaliana and Gerbera hybrida were introduced in a S. cerevisiae strain producing naringenin, the flavonoid precursor of anthocyanins. Upon culturing, pelargonidin and its 3-O-glucoside were detected inside the yeast cells, albeit at low concentrations. A number of related intermediates and side-products were much more abundant and were secreted into the culture medium. To optimize titers of pelargonidin 3-O-glucoside further, biosynthetic genes were stably integrated into the yeast genome, and formation of a major side-product, phloretic acid, was prevented by engineering the yeast chassis. Further engineering, by removing two glucosidases which are known to degrade pelargonidin 3-O-glucoside, did not result in higher yields of glycosylated pelargonidin. In aerated, pH controlled batch reactors, intracellular pelargonidin accumulation reached 0.01 µmol/g

conclusionThe results reported in this study demonstrate the proof-of-concept that S. cerevisiae is capable of de novo production of the anthocyanin pelargonidin 3-O-glucoside. Furthermore, while current conversion efficiencies are low, a number of clear bottlenecks have already been identified which, when overcome, have huge potential to enhance anthocyanin production efficiency. These results bode very well for the development of fermentation-based production systems for specific and individual anthocyanin molecules. Such systems have both great scientific value for identifying and characterising anthocyanin decorating enzymes as well as significant commercial potential for the production of, on-demand, pure bioactive compounds to be used in the food, health and even pharma industries.

Indexed as

AnthocyaninsArabidopsisBatch Cell Culture TechniquesBiological ProductsBiosynthetic PathwaysCulture MediaFermentationFlavanonesFlavonoidsGlucoseKaempferolsMetabolic EngineeringPhenylpropionatesPlant ProteinsProof of Concept StudySaccharomyces cerevisiaeAnthocyaninsaromadedrinBiological ProductsCulture MediaFlavanonesFlavonoidsGlucosekaempferolKaempferolsnaringeninpelargonidinPhenylpropionatesphloretic acidPlant ProteinsAnthocyaninFlavonoidsMetabolic engineeringNatural productsPelargonidinPlant secondary metabolitesSaccharomyces cerevisiae

Identifiers

PMID29970082
PMCPMC6029064
OpenAlexW2811452837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.